About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, October 11th, 2017

The QualityStocks
Daily Stock List


SCI Engineered Materials, Inc. (SCIA)

InvestorsHub and OTC Markets reported on SCI Engineered Materials, Inc. (SCIA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

SCI Engineered Materials, Inc. is a worldwide supplier and manufacturer of advanced materials for physical vapor deposition (PVD) thin film applications. This includes thin film solar products. The Company works closely with end users and original equipment manufacturers (OEMs) to develop innovative, customized solutions. SCI Engineered Materials is headquartered in Columbus, Ohio.

The Company provides targeted solutions for thin film applications. SCI is an ISO 9001-2015 Registered Provider of PVD Materials. It is a “Full Service Materials Provider” for PVD applications. The Company is a recognized leader in the development of “Transparent Conductive Oxide (TCO)” materials for diverse industries. SCI continues development with Universities and Research Institutes globally.

The major markets that SCI Engineered Materials serves include architectural glass, optic & photonic, solar photovoltaic, transparent electronics, and solid state lithium thin film battery. The Company provides precision machining of backing plates & tubes to customer or OEM specifications.

SCI provides ceramic and metal targets for use in sputtering and laser ablation systems. In addition, the Company manufactures high performance metal, ceramic, and alloy bulk-form evaporation sources in almost any customer defined configuration.

Moreover, SCI processes a broad array of custom ceramic powders in house. It offers a wide variety of single crystal substrates for making premier thin films. Services that SCI provides include advanced ceramic powers, vacuum hot pressing, machining, bonding, and quality assurance.

In June 2017, SCI Engineered Materials announced that it entered into a joint project with Case Western Reserve in their Summer Undergraduate Research in Energy and Sustainability program. The aim of the project is to measure the band gaps and work function of a number of materials now undergoing development by SCI via in-house research and development (R&D) activities.

Case Western Reserve will evaluate test films to ascertain if SCI's materials have superior properties to replace Cadmium Sulfide and/or intrinsic Zinc Oxide in Copper Indium Gallium Selenide (CIGS) thin film solar products.

Last week, SCI Engineered Materials announced Case Western Reserve University’s (CWRU) successful evaluation of test films using SCI’s Zinc Magnesium Oxide (MZO) material. The results support use of SCI’s unique material in thin film solar applications, which could lead to higher efficiencies.

SCI Engineered Materials, Inc. (SCIA), closed Wednesday's trading session at $1.34, even for the day, on 4,225 volume with 3 trades. The average volume for the last 60 days is 3,474 and the stock's 52-week low/high is $0.40/$1.34.

Affinor Growers, Inc. (RSSFF)

Vantage Wire reported earlier on Affinor Growers, Inc. (RSSFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Affinor Growers, Inc. is a diversified agriculture and biotechnology company listed on the OTC Markets Group’s OTCQB. It has proprietary vertical farming systems. The Company’s concentration is on growing high quality crops, including romaine lettuce, spinach, and strawberries employing its vertical farming techniques. The Company has experience in the production and trade of agricultural products. Affinor's aim over the next year is to shift from a development to an operational company, centering on producing revenue from vertical tower sales, license agreements, and introducing new agriculture technologies. Affinor Growers is based in Vancouver, British Columbia.

The Company’s present plan includes continuing the development and commercialization of the technology and equipment, validation through third party partners, and constructing a pilot plant to prove commercialization and revenue models providing the sales tools for license agreements and revenue.

Affinor’s commitment is to become a pre-eminent supplier and grower, utilizing exclusive vertical farming techniques. In essence, Affinor’s mission is to develop technology for growing better food. It designs patented, and commercializes, vertical farming technology for the indoor controlled environment and the outdoor greenhouse agriculture industry.

Affinor Growers’ advisers and network range from large scale retail, local farmers, international berry producers, large greenhouse farmers, cannabis expert growers, strawberry experts, and distributors. The Company’s goal is to transform greenhouse vertical farming through providing the highest plant density per square meter using its patented vertical growing technology.

Over the last year, Affinor Growers has centered on strawberry development. Fresh strawberries account for 80 percent of the total strawberry production in North America valued at $2.6 billion each year.

The Company will continue to grow and harvest strawberries with its beta prototypes installed at the University of Fraser Valley throughout the summer, fall and winter of 2018. The emphasis will continue on standardizing crop models and ascertaining best practices for commercialization.

Affinor Growers, Inc. (RSSFF), closed Wednesday's trading session at $0.0566, down 2.92%, on 19,786 volume with 8 trades. The average volume for the last 60 days is 38,189 and the stock's 52-week low/high is $0.0382/$0.1822.

Digerati Technologies, Inc. (DTGI)

AllPennyStocks, MicrocapVoice, OTCPicks, and SmallCapVoice reported earlier on Digerati Technologies, Inc. (DTGI) and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Digerati Technologies, Inc. is a diversified holding headquartered in San Antonio, Texas. The Company has subsidiary operations in the cloud communications industry. Digerati, by way of its wholly-owned subsidiary, Shift8 Technologies, Inc., provides Internet-based telephony products and services through its cloud telephony application platform and session-based communication network. In essence, Digerati Technologies is an established and award-winning provider of cloud communication services.

Digerati Technologies serves traditional carriers, telephony resellers, and other VoIP (Voice over Internet Protocol) carriers in the U.S. and globally. Its Shift8 Networks subsidiary is an enterprise hosted PBX and cloud-based Unified Communications service provider. Shift8 Networks provides voice, video, and mobile communications to thousands of businesses through its Channel Alliance program.

Shift8 integrates hosted VoIP with cloud-based messaging and desktop applications. Shift8 Networks earlier entered into a new partnership with Tenfold, the top phone intelligence platform for the entire customer lifecycle. Via this partnership, Shift8’s clients can now quickly connect their cloud communication system with greater than 25 Customer Relationship Management (CRM) systems and Help Desk applications.

Digerati Technologies provides voice over Internet protocol (VoIP) communication services to telecommunications enterprises. It provides Internet-based services. These include fully hosted IP/PBX services, IP trunking, call center applications, prepaid services, and interactive voice response auto attendant. Furthermore, services include call recording, simultaneous calling, voicemail to email conversion, and multiple customized IP/PBX features in a hosted or cloud environment for specialized applications.

This past June, Digerati Technologies announced that Shift8 Networks entered into a Value-Added Reseller (VAR) agreement with First Service Technology (FST) to serve the Kindergarten through 12th Grade (K-12) Education, along with the City and County Government markets in the State of Texas. FST, (San Antonio, Texas) with offices in Houston and the Rio Grande Valley of South Texas, delivers unique, value-added technology and security solutions across the Texas K-12 Education, City, County and Commercial Markets.

Shift8 provides Partners like FST with a go-to-market capability for delivering cloud communication solutions. Shift8's VAR program targets PBX Vendors, Information Technology (IT) Services firms, Managed Service Providers, and Systems Integrators, which lack a cloud telephony infrastructure, but have an embedded customer base that requires Internet-based telephony services.

Digerati Technologies has entered into a definitive agreement to acquire T3 Communications, Inc. of Fort Myers, Florida. T3 is a foremost provider of cloud communication and broadband solutions in Southwest Florida.

Digerati Technologies, Inc. (DTGI), closed Wednesday's trading session at $0.33, even for the day, on 100 volume with 1 trade. The average volume for the last 60 days is 4,159 and the stock's 52-week low/high is $0.135/$2.25.

Minera Alamos, Inc. (VGMTF)

MarketWatch, TradingView, OTC Markets, The Street, AwesomePennyStocks, 4-Traders, Capital Cube, and Stockhouse reported on Minera Alamos, Inc. (VGMTF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Minera Alamos, Inc. is an advanced stage exploration and development company listed on the OTC Markets Group’s OTCQB. The Company’s growing portfolio of high-grade Mexican projects includes the La Fortuna open pit gold project in Durango and the Los Verdes open pit copper-molybdenum project in Sonora. Minera Alamos is headquartered in Toronto, Ontario. The Company has its Mexican Operations office in Hermosillo, Sonora, Mexico.

Minera Alamos is well funded to conduct all of its planned exploration and development activities. The Company continues to pursue additional project acquisitions in Latin America.

The La Fortuna open pit gold project in Durango is an advanced project acquired in 2016 from Argonaut Gold. It is high grade. There is the potential for significant resource growth.

The Los Verdes open pit copper-molybdenum project in Sonora is high grade. It has 10-plus years of low strip mineralization. In addition, it has first-rate site infrastructure. There is the potential for a long-life regional metallurgical facility.

Recently, Minera Alamos announced that it hired Mr. Robelsis Altamirano, P.Eng, to manage advanced exploration activities aimed at expanding the resource base at the Company’s flagship La Fortuna gold project. Mr. Altamirano worked previously with the Company’s Mexican technical team. He was the exploration manager for Argonaut Gold’s (previously Castle Gold) south extension of the El Castillo gold mine.

Mr. Altamirano has wide-ranging experience managing exploration programs in Mexico with the Mexican Geological Service (SGM - Servicio Geologico Mexicano) and many independent mining groups. Minera Alamos’ intention is to start production at one or more projects next year.

The Company is currently concentrating on opportunistically obtaining and developing high quality mining projects. These projects will be one to two years away from production. In addition, they will be capable of high operating margins. In addition, they will be modest in size and capital expenditure (capex).

On September 11, 2017, Minera Alamos announced it received approval for an OTCQB listing in the U.S. The OTCQB Marketplace is for developing U.S. and global companies.

Mr. Darren Koningen, Minera Alamos’ President and Chief Executive Officer, said, “We are pleased to announce the conclusion of our efforts to elevate the status of our share trading in the U.S. to the OTCQB. The listing will provide enhanced access for the Company to investors in the world’s largest equity market. Management believes it will also create a wider awareness of the Company’s ongoing progress as it advances the La Fortuna gold project towards production.”

Minera Alamos, Inc. (VGMTF), closed Wednesday's trading session at $0.1439, even for the day. The average volume for the last 60 days is 42,736 and the stock's 52-week low/high is $0.10/$0.1831.

Freedom Leaf, Inc. (FRLF)

CFN Media Group, SmallCapVoice, Promotion Stock Secrets, and StocksToBuyNow reported on Freedom Leaf, Inc. (FRLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a top go-to resource in the cannabis, medical marijuana, as well as industrial hemp industry. The Company engages in mergers and acquisitions (M&A’s) in the marijuana industry. This includes incubation/acceleration and spin offs of new marijuana/hemp related companies. The Company does not handle, grow, sell, or disperse marijuana.

Freedom Leaf targets acquisitions of high growth and niche companies. Its business strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development. OTCQB-listed, Freedom Leaf has its corporate office in Las Vegas, Nevada.

The Company’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-changing and developing cannabis, medical marijuana, and industrial hemp industry.

The content Freedom Leaf produces and curates chiefly attracts industry professionals, including lawyers, legislators, activists, entrepreneurs, and people active in the business of cannabis and industrial hemp. The Freedom Leaf enterprise has become a leader in media production and distribution for the cannabis/hemp industry.

Freedom Leaf has acquired LaMarihuana.com. This is the Spanish Speaking community's foremost cannabis website. As part of this acquisition, Freedom Leaf acquired www.Marihuana-Medicinal.com. This is the largest Medical Cannabis information website in Spanish.

In late August, Freedom Leaf reported major developments in its Spanish acquisition, Green Market Europe (GME), in combination with University Miguel Hernández in Elche, Spain. Freedom Leaf and GME signed a Letter of Intent (LOI) for Freedom Leaf to acquire 100 percent of GME's IP, projects, and assets.

Freedom Leaf paid the cash stipulated in the contract as a deposit of the full transaction. Freedom Leaf has agreed to expand two additional growing operations worldwide before the end of 2019 to maximize the skills and the potential of staff. GME facilities include a 21,000-sq. ft. light deprivation greenhouse, which allows increasing the number of crops per year, a 43,000-sq. ft. greenhouse and indoor growing facility for Genetic research.

Freedom Leaf will be making presentations at two major financial conferences this month, at the New West Summit in Oakland, California (Oct. 13, 14, 15), and at the Alternative Asset ReLeaf Summit (Oct. 23) in Las Vegas, Nevada.

Freedom Leaf, Inc. (FRLF), closed Wednesday's trading session at $0.039, up 11.43%, on 29,610 volume with 8 trades. The average volume for the last 60 days is 224,799 and the stock's 52-week low/high is $0.0288/$0.31.

Citius Pharmaceuticals, Inc. (CTXR)

MicroCapDaily, Stock Commander, Penny Stock Prodigy, DSR News, PHUB News, Damn Good Penny Picks, Penny Picks, OTCtipReporter, PennyStockScholar, Profitable Trader Authority, OTCMagic, Penny Stock Newsletter, and PREPUMP STOCKS reported previously on Citius Pharmaceuticals, Inc. (CTXR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products. The Company’s concentration is on anti-infectives, cancer care, and innovative prescription products utilizing unique, patented, or proprietary formulations of earlier approved active pharmaceutical ingredients. Citius Pharmaceuticals is headquartered in Cranford, New Jersey.

The Company is now advancing two proprietary product candidates: the Mino-Lok™ product and a hydrocortisone-lidocaine formulation. The Mino-Lok™ product is advancing to Phase 3 clinical studies. The Mino-Lok™ product is an antibiotic lock solution. It is used to treat patients with catheter-related bloodstream infections (CRBSIs). Mino-Lok™ is under investigation and not approved for commercial use.

Citius Pharmaceuticals is developing a proprietary topical formulation of hydrocortisone (3%) and lidocaine (5%) to provide anti-inflammatory and anesthetic relief to persons suffering from Grade I and II hemorrhoids. The Company has achieved positive results from a Phase 2a study for hydrocortisone-lidocaine formulation for Grade I and II hemorrhoids.

Citius Pharmaceuticals has commenced the pivotal Phase 3 clinical trial Mino-Lok™. This is the above-mentioned antibiotic lock solution used to salvage infected central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs). Mino-Lok™ is undergoing development as an adjunctive therapy for the treatment of catheter-related or central line associated bloodstream infection (CRBSI/CLABSI). Mino-Lok™ together with suitable systemic antibiotic(s), is used to preserve central venous access and to avoid the complications and morbidities associated with catheter removal and reinsertion.

The Company has obtained top line data from a survey of 31 physicians clearly showing a need for catheter salvage in patients with indwelling central venous lines, especially when the catheter is a tunneled or an implanted port. Nineteen Infectious Disease experts and 12 Intensivists surveyed all agreed that salvage would be preferable to catheter exchange, fearing that catheter misplacements, blood clots, or vessel punctures can potentially occur during reinsertion. Most were also concerned that viable venous access may not be available. The survey was conducted by a third party in January of this year.

In March 2017, Citius Pharmaceuticals announced that it concluded negotiations to add South America to its global license for Mino-Lok™. South America was the only territory that was not included in the original sub-license between Novel Anti-Infective Technologies, LLC, an affiliate of MD Anderson Cancer Center (MDACC), and Leonard-Meron Biosciences, Inc. (LMB), a wholly-owned subsidiary of Citius Pharmaceuticals.

Citius Pharmaceuticals, Inc. (CTXR), closed Wednesday's trading session at $3.77, up 5.31%, on 175,678 volume. The average volume for the last 30 days is 36,268 and the stock's 52-week low/high is $2.55/$14.85.


The QualityStocks
Company Corner


RJD Green Inc. (RJDG)

The QualityStocks Daily Newsletter would like to spotlight RJD Green Inc. (RJDG). Today, RJD Green Inc. closed trading at $0.009, up 7.14%, on 1,534,486 volume with 27 trades. The stock’s average daily volume over the past 60 days is 1,951,768, and its 52-week low/high is $0.0024/$0.029.

RJD Green Inc. (RJDG) is a holding company with a focus on acquiring and managing assets and companies in three divisions. These initial high-growth enterprise opportunities offer diversity in separate recession resistant markets. The division holdings include:

  • RJD Green Healthcare Services – provides services to reduce cost and enhance management and operational capabilities in the healthcare sector.
  • Earthlinc Environmental Services – provides green environmental services and technologies.
  • Silex Holdings – acquires specialty construction and industrial manufacturing assets.

RJD Green Healthcare Services, through its wholly owned subsidiary IOSOFT Inc., provides proprietary software and IT support for medical billing, healthcare claims adjudication, and electronic payments between healthcare payers and providers. IOSOFT's unique payment technologies and services or software can be integrated with existing systems of healthcare payers such as Blue Cross, Aetna, CIGNA and others. IOSOFT provides targeted offerings for healthcare providers, provider networks, physicians and hospitals, and clearinghouse companies.

Earthlinc Environmental Solutions was formed to bring forward green-applied technologies and offer environmental services with a focus on North America. The division's first acquisition, Animal Waste Management, is launching operations of a patented, fully developed technology for processing waste produced on commercial poultry and hog farms. Development of this technology was supported by the University of Arkansas and the Missouri Department of Natural Resources. This important technology improves the farm's productivity and is competitively priced with the current expense of handling waste removal at these sites.

The company's third division – Silex Holdings Inc. – was formed to acquire and manage high-growth assets and business enterprises in the industrial and construction specialty services sectors. With its first acquisition of Silex Interiors, a manufacturer, distributor and installer of counter tops, cabinets and related kitchen and bath products, the division is poised to expand into major national markets through internal expansion, acquisition and franchising. The company is modeled to operate a minimum of four corporately owned locations with 12 to 18 franchise locations nationwide.

RJD Green seeks to participate as owners, partners or in joint ventures in a wide range of business enterprises. The company's goal of creating a successful, enjoyable business enterprise for its company team and staff, along with its business partners and investors, is paired with the goal of maximizing the business potential of the enterprise by enhancing profits and the quality of the company. Disclaimer

RJD Green Inc. Company Blog

RJD Green Inc. News:

RJD Green Inc. Subsidiary, IOSOFT, Discusses Contracts Procured and Revenue Expectations

RJD Green Inc. Announces The Silex Holdings Division Contract Awarded as Preferred Vendor

RJD Green Inc. Subsidiary, Enters Acquisition Discussions with Healthcare Consulting Firm

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.06278, up 9.18%, on 5,766,754 volume with 398 trades. The stock’s average daily volume over the past 60 days is 20,087,896, and its 52-week low/high is $0.0075/$0.415.

SinglePoint, Inc. (OTC: SING) announces the completion of a $4 Million round of funding, $1.2 Million of which has already been collected including $600,000 of which came from United American HealthCare Corp (OTC: UAHC). With this new round of funding, SinglePoint is positioned to aggressively develop and complete its Bitcoin Payments solution and acquire additional companies in the cannabis space. Also today, CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for the cannabis industry, announced the publication of an editorial featuring SinglePoint, Inc. (OTC: SING), a client of CNW focused on strengthening its position in the marijuana industry through the acquisition of, or investment in, small to mid-sized cannabis companies. The publication, titled, "Green Rush Offers Enticing Secondary Business Opportunities," discusses various companies that provide products and services related to the broader cannabis economy. To view the full publication, visit: https://www.cannabisnewswire.com/green-rush-offers-enticing-secondary-business-opportunities/

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint Receives $1.2 Million in Funding With Option to Raise a Total of $4 Million

CannabisNewsWire Announces Publication Discussing the Diverse Landscape of the Cannabis Industry

CannabisNewsWire Announces Publication on Public Companies Providing Ancillary Services to the Cannabis Sector

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.57, even for the day, on 83,068 volume with 65 trades. The stock’s average daily volume over the past 60 days is 105,560 and its 52-week low/high is $0.33/$2.75.

ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, today announces that the Company has launched the first cryptocurrency daily video newscast in the Chinese language, entitled Bitcoin Multimillionaire, broadcast from the NYSE. The video newscast covers timely information and analysis regarding all aspects of the emerging digital currency world, including specific cryptocurrencies, such as Bitcoin and Ethereum, industry trends, price movement, blockchain technology, and sector-related stocks and ETFs listed on major exchanges and the OTC market.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

ChineseInvestors.com, Inc. Launches Bitcoin Multimillionaire, the First Daily Video Cryptocurrency Newscast in the Chinese Language, With Plans to Launch a New Cryptocurrency Website Under the Domain 'newcoin168.com'

SeeThruEquity Issues Update on ChineseInvestors.com Inc. (OTCQB: CIIX)

ChineseInvestors.com, Inc. Appoints Skin Care Industry Veteran and Shanghai Beauty Influencer, Fannie Tang, as Marketing Director of its Wholly-owned Foreign Enterprise, CBD Biotechnology Co., Ltd.

Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB:PTOTF)

The QualityStocks Daily Newsletter would like to spotlight Patriot One Technologies, Inc. (PTOTF). Today, Patriot One Technologies, Inc. closed trading at $1.25, up 3.50%, on 962,597 volume with 828 trades. The stock’s average daily volume over the past 60 days is 108,801, and its 52-week low/high is $0.4665/$1.49.

Patriot One Technologies Inc. (TSX VENTURE: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) ("Patriot One" or the "Company") is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the "Underwriters") pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 7,100,000 units (the "Units") at a price of $1.20 per Unit (the "Offering Price") for aggregate gross proceeds to Patriot One of $8,520,000 (the "Offering"). Also today, the company was pleased to announce that it has entered into an amending agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the "Underwriters") to increase the size of its previously announced bought deal financing. Pursuant to the revised terms of the offering, the Underwriters have agreed to purchase, on a bought deal basis, an aggregate of 8,350,000 units (the "Units") at a price of $1.20 per Unit (the "Offering Price") for aggregate gross proceeds to Patriot One of $10,020,000 (the "Offering").

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.

Developed through a NATO-funded project at McMaster University, Patriot One's disruptive NForce CMR1000 technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.

A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world's population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren't taken.

Patriot One's patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a "cognitive" ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.

In contrast, Patriot One's technology is small in size and can be "covertly" placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.

The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.

The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.

Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols. Disclaimer

Patriot One Technologies, Inc. Company Blog

Patriot One Technologies, Inc. News:

Patriot One Technologies Inc. Announces an Increase to the Previously Announced Bought Deal Financing

Patriot One Technologies Inc. Announces $8.5 Million Bought Deal

Patriot One Technologies Inc. Announces Listing of Warrants

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.0613, off by 0.62%, on 2,485,754 volume with 170 trades. The stock’s average daily volume over the past 60 days is 4,078,156, and its 52-week low/high is $0.002/$0.0995.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding, Inc. Continues to Strengthen Advisory Board with the Appointment of Distinguished Medical Marijuana Certified Physician

Global Payout’s MoneyTrac Technology, Inc. Enters Final Stages of Revenue-Generating Joint Venture Partnership with Established Financial Institution to Deliver Banking Solutions to the Cannabis Industry

Continuing to Structure for Robust and Targeted Growth, PotNetwork Holding, Inc. Appoints Dr. Richard Goulding as New Chief Executive Officer

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.375, up 0.11%, on 324,710 volume with 131 trades. The stock’s average daily volume over the past 60 days is 458,281, and its 52-week low/high is $0.09/$0.72.

InMed Pharmaceuticals Inc. (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce the addition of Dr. Mauro Maccarrone to its Scientific Advisory Board.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board

InMed Pharmaceuticals Files Provisional Patent for Pain Program

NetworkNewsWire Announces Publication Highlighting Companies Engaged in Advanced Cannabinoid Research


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(DRWIQ) +172.73%


Daily Trade Alert
(TIPS) +156.41%


(LBIX) +55.81%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251